Gefitinib and ginsenoside Rg3 together dramatically boost apoptosis in non-small cell lung cancer cells by upregulating the pro-apoptotic protein Bax and caspase-3 activity while downregulating the anti-apoptotic protein Bcl-2 [220]. This evidence concerns the gene CASP3 and non-small cell lung carcinoma.